Biesemeyer, H

Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease. [electronic resource] - Journal of neurology 1983 - 19-23 p. digital

Publication Type: Journal Article

0340-5354

10.1007/BF00313593 doi


Adult
Aged
Amantadine--administration & dosage
Antiparkinson Agents
Bromocriptine--administration & dosage
Carboxy-Lyases--antagonists & inhibitors
Drug Therapy, Combination
Ergolines--administration & dosage
Female
Humans
Levodopa--administration & dosage
Male
Middle Aged
Parasympatholytics--administration & dosage
Parkinson Disease--drug therapy